Main Article Content
HIV Facial lipoatrophy correction with autologous whole blood as filler
Abstract
A patient with Human immunodeficiency virus (HIV)-related lipoatrophy
presented for volume correction of the mid-face. He suffers from pre-existing osteoma cutis and there was concern that non-autologous fillers could activate new osteoma lesions and worsen existing ones. We describe a method of autologous whole blood transfer and subcision for lipoatrophy correction without synthetic or bio-stimulating fillers. Under infraorbital nerve block, the treated area is first subcised with a 19-gauge needle in a fanning motion. This is followed by subdermal injection of autologous whole blood (5 to 10 mL per cheek) into the lipoatrophic areas. Serial treatment sessions produced a noticeable improvement in the facial volume and contour, eve n up to 5 months post treatment. Bruising was minimal and subtle and no other complications were encountered. Subcision with autologous whole blood injection is a potentially low-cost and effective treatment option to restore facial volume where use of bio-stimulating fillers is either not readily available or contraindicated.
presented for volume correction of the mid-face. He suffers from pre-existing osteoma cutis and there was concern that non-autologous fillers could activate new osteoma lesions and worsen existing ones. We describe a method of autologous whole blood transfer and subcision for lipoatrophy correction without synthetic or bio-stimulating fillers. Under infraorbital nerve block, the treated area is first subcised with a 19-gauge needle in a fanning motion. This is followed by subdermal injection of autologous whole blood (5 to 10 mL per cheek) into the lipoatrophic areas. Serial treatment sessions produced a noticeable improvement in the facial volume and contour, eve n up to 5 months post treatment. Bruising was minimal and subtle and no other complications were encountered. Subcision with autologous whole blood injection is a potentially low-cost and effective treatment option to restore facial volume where use of bio-stimulating fillers is either not readily available or contraindicated.
